Alan B. Sandler Insider Profile
4 Followers
Alan B. Sandler, Chief Development Officer at Revolution Medicines, holds 52.87K shares in Revolution Medicines (Ticker: RVMD), holds 0.00 shares in Mirati Therapeutics (Ticker: MRTX), holds 28.98K shares in Zai Lab (Ticker: ZLAB).
Alan B. Sandler has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Alan B. Sandler holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Alan B. Sandler
Alan B. Sandler's Trading History
Revolution Medicines
Sep 18, 2026
Chief Development Officer
Uninformative Sell
67.94K
$10.85M
Zai Lab
Apr 05, 2022
Head of Global Dev., Oncology
Uninformative Buy
48.20K
$763.46K
Mirati Therapeutics
Jan 23, 2024
―
Uninformative Sell
―
$0.00
Elevation Oncology
―
―
―
―
ALX Oncology Holdings
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Alan B. Sandler's performance on stock
You May Also Like
Alan B. Sandler insider profile FAQ
What is the percentage of profitable transactions made by Alan B. Sandler?
The percentage of profitable transactions made by Alan B. Sandler is ―.
What is the average return per transaction made by Alan B. Sandler?
The average return per transaction made by Alan B. Sandler is ―.
What stocks does Alan B. Sandler hold?
Alan B. Sandler holds: RVMD, ZLAB, MRTX, ELEV, ALXO stocks.
What was Alan B. Sandler’s latest transaction?
Alan B. Sandler latest transaction was an Uninformative Sell of $67.94K.
What was Alan B. Sandler's most profitable transaction?
Alan B. Sandler’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Alan B. Sandler's role in Revolution Medicines?
Alan B. Sandler's role in Revolution Medicines is Chief Development Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.